Insider · CIK 0001742143

Pizzie Nick

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001742143

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+33K sh	$3.50	+$116K	75,867
2026-06-09	AXSMAxsome Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−33K sh	$240.09	−$7.92M	42,867
2026-06-09	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−33K sh	—	—	72,000
2026-04-21	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Financial Officer	AAward	+8,188 sh	—	—	8,188
2026-02-26	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+18.6K sh	—	—	18,570
2026-01-22	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12K sh	$3.50	+$42K	54,588
2026-01-22	AXSMAxsome Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−12K sh	$187.92	−$2.26M	42,588
2026-01-22	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12K sh	—	—	105,000
2025-02-24	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Financial Officer	AAward	+9,423 sh	—	—	9,423
2025-02-21	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+9,516 sh	—	—	9,516
2025-02-21	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+9,423 sh	—	—	9,423
2025-02-14	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$3.50	+$10.5K	45,187
2025-02-14	AXSMAxsome Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,000 sh	$131.07	−$393K	42,187
2025-02-14	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	$3.50	−$10.5K	0
2025-02-13	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12K sh	$3.50	+$42K	54,187
2025-02-13	AXSMAxsome Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−12K sh	$129.86	−$1.56M	42,187
2025-02-13	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12K sh	$3.50	−$42K	0
2024-02-27	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+28.7K sh	—	—	28,722
2024-02-27	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+15.8K sh	—	—	15,774
2023-03-02	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+36.2K sh	—	—	36,246
2023-03-02	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+20.6K sh	—	—	20,554
2022-03-04	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+77.9K sh	—	—	77,872
2022-03-04	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+41.2K sh	—	—	41,176
2021-11-18	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+527 sh	$35.50	+$18.7K	41,789
2021-11-18	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+141 sh	$35.43	+$4,995.63	201
2021-11-18	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+145 sh	$34.30	+$4,973.5	145
2021-11-18	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+142 sh	$35.20	+$4,998.4	142
2021-11-12	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+36.1K sh	—	—	36,086
2021-03-05	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+36.1K sh	—	—	36,086
2021-03-05	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+19.2K sh	—	—	19,208
2020-06-29	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+777 sh	$76.64	+$59.5K	41,217
2020-03-17	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60.9K sh	—	—	60,880
2020-03-17	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+18.6K sh	—	—	18,645
2020-03-17	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+48.2K sh	—	—	48,237
2020-03-17	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+14.8K sh	—	—	14,767
2019-10-10	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+25.8K sh	—	—	25,813
2019-09-26	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,180 sh	$24.80	+$54.1K	40,440
2019-06-11	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,920 sh	$20.80	+$39.9K	1,920
2019-03-19	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+60 sh	$12.69	+$761.4	60
2019-03-19	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,340 sh	$12.58	+$67.2K	36,340
2019-03-19	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+75.1K sh	—	—	75,102
2018-06-19	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+400 sh	$3.05	+$1,220	400
2018-06-19	AXSMAxsome Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+30.6K sh	$3.10	+$94.9K	31,000
2018-05-16	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+132K sh	—	—	132,000

Recent filings

Accepted (ET)
Jun 94
Pizzie Nick0001193125-26-264035
SEC(opens sec.gov)
Apr 234
Pizzie Nick0001193125-26-174412
SEC(opens sec.gov)
Feb 274
Pizzie Nick0001193125-26-083608
SEC(opens sec.gov)
Jan 234
Pizzie Nick0001193125-26-021378
SEC(opens sec.gov)
Feb 254
Pizzie Nick0000950170-25-027070
SEC(opens sec.gov)
Feb 144
Pizzie Nick0000950170-25-021716
SEC(opens sec.gov)
Feb 294
Pizzie Nick0000950170-24-023364
SEC(opens sec.gov)
Mar 64
Pizzie Nick0001209191-23-016457
SEC(opens sec.gov)

Companies

Axsome Therapeutics, Inc.Chief Financial OfficerAXSM

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007